Table 1 Baseline characteristics
| Â | GA (172) | RA (480) | OA (206) |
|---|---|---|---|
Serum uric acid, mean, mmol/l (SD) | 0.36 (0.14) | 0.31 (0.075)** | 0.31 (0.0832)** |
Hyperuricaemia, n (%) | 54 (32)†| 62 (14)†| 34 (17)†|
Uric acid lowering therapy, n (%) | 126 (73) | 0 | 0 |
Allopurinol, n (%) | 111 (65) | 0 | 0 |
Sex, n (%) male | 154 (89) | 133 (28)** | 43 (21)** |
Age, mean, years (SD) | 59.6 (10.8) | 59.0 (13.0) | 59.2 (11.0) |
Systolic blood pressure, mean, mmHg (SD) | 151.0 (21.3) | 144.0 (22.9)** | 145.5 (20.2)** |
Antihypertensive therapy, n (%) | 67 (39.0) | 118 (24.6) | 71 (34.5) |
Smoking, n (%) | 43 (25) | 114 (24) | 38 (18) |
TC/HDL ratio, mean (SD) | 4.82 (1.4)†| 3.65 (1.1)†| 4.0 (1.2)†|
Total cholesterol, mean (SD) | 5.32 (1.1) | 5.30 (1.0) | 5.57 (1.1) |
HDL cholesterol, mean (SD) | 1.17 (0.32) | 1.53 (0.43) | 1.48 (0.39) |
Statin therapy, n (%) | 22 (12.8) | 32 (6.7)‡ | 26 (12.6) |
Diabetes, n (%) | 11 (6.4) | 28 (5.8) | 16 (7.8) |
GlyHb, mean, % Hb (SD) | 6.1 (1.4) | 5.5 (1.8) | 6.0 (4.2) |
BMI, mean, kg/m2 (SD) | 30.4 (4.7)†| 27.0 (4.3)†| 28.8 (5.3)†|
MDRD, mean, ml/min (SD) | 80.8 (21.8) | 89.9 (19.5)** | 87.7 (18.7)** |
NT proBNP, mean, nmol/L (SD) | 37.6 (170.6) | 15.9 (25.8)** | 15.1 (32.8)** |
hsCRP, mean, g/L (SD) | 6.3 (11.2) | 7.0 (10.0) | 3.8 (4.9)* |
Corticosteroids, n (%) | 0 (0.0) | 68 (14.2)Â¥ | 1 (0.50) |